Effect on efficacy and safety trial outcomes of also enrolling patients on ongoing glucocorticoid therapy in rheumatoid arthritis clinical trials of tocilizumab or adalimumab or methotrexate monotherapy

Mary Safy-Khan*, Johannes W.G. Jacobs, Maria J.H. De Hair, Paco M.J. Welsing, Michael D. Edwardes, Xavier M. Teitsma, Yves Luder, Jenny Devenport, Jacob M. Van Laar, Attila Pethoe-Schramm, Johannes W.J. Bijlsma

*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

Fingerprint

Dive into the research topics of 'Effect on efficacy and safety trial outcomes of also enrolling patients on ongoing glucocorticoid therapy in rheumatoid arthritis clinical trials of tocilizumab or adalimumab or methotrexate monotherapy'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemistry